The global medical central oxygen supply system market was valued at USD 440 million in 2025. The market is projected to grow from USD 480 million in 2026 to USD 966 million by 2034, exhibiting a compound annual growth rate of 9.14% during the forecast period. Contrive Datum Insights presents this information in its report titled "Medical Central Oxygen Supply System Market Size, Share & Industry Analysis, By Product type (Pure Medical Gases, Medical Gas Mixtures, Compressors, Cylinders, Hose Assemblies and Valves, Masks, Vacuum Systems, Regulator, Others), Application (Therapeutic, Diagnostics, Others), End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic and Research Laboratories, Others), System type (Liquid Oxygen (VIE) Systems, PSA Oxygen Generator Systems, Cylinder Manifold Systems), Component (Equipment, Installation and Commissioning Services, Maintenance and Aftermarket Services), and Regional Forecast, 2026-2034".
A medical central oxygen supply system delivers medical-grade oxygen from a single source, whether a liquid oxygen tank, an on-site pressure swing adsorption generator, or a cylinder manifold, through a piped distribution network to multiple points of use within a healthcare facility. The category covers the generation or storage equipment, the compressors and vacuum components that maintain pressure and flow, and the valves, regulators and outlet fittings that connect the network to bedside and procedure-room terminals. Buyers are hospitals, ambulatory surgical centers and diagnostic facilities that need continuous, code-compliant oxygen delivery instead of relying on individual portable cylinders.
On-site oxygen generation adoption following supply disruptions
On-site oxygen generation adoption following supply disruptions is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 9.14% a year, the product type lines exposed to it move fastest: Compressors compounds at 14.03%, taking its share of revenue from 16% to 24% and its value from USD 70.4 million to USD 231.8 million.
Where the forecast could be beaten: hospital capital budgets accelerate faster than assumed, and on-site generator adoption in cost-constrained markets moves faster than the base case. The study puts that case at USD 1050 million in 2034, against USD 966 million in the base.
Against that, hospital capital spending is constrained by broader public health budget pressure, slowing both new installations and the conversion from cylinder and liquid oxygen systems to on-site generation. On that reading 2034 revenue stops at USD 866 million. The weight of the problem sits in Cylinders: 20% of 2025 revenue growing at 6.43%, well under the market's 9.14%.
Cylinders Scale Against Compressors Momentum
Two positions matter, and they are set by product type. Cylinders carries 20% of 2025 revenue (USD 88 million) and is still the largest line in 2034 at 16%, hard to take from an incumbent. Compressors, at 14.03%, is where the USD 440 million base is redistributed. The two demand different capabilities.
What Else the Report Shows
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product type | Cylinders | 20% · USD 88 million | — |
| Application | Therapeutic | 78% · USD 343.2 million | Others 10.75% |
| End-user | Hospitals | 68% · USD 299.2 million | Ambulatory Surgical Centers 11.37% |
| System type | Liquid Oxygen (VIE) Systems | 42% · USD 184.8 million | PSA Oxygen Generator Systems 12.09% |
| Component | Equipment | 58% · USD 255.2 million | Maintenance and Aftermarket Services 12.15% |
- Asia Pacific was the largest region in 2025, holding 30% of global revenue at USD 132 million and reaching USD 328.4 million by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 30% in 2025 to 34% in 2034, with revenue growing from USD 132 million to USD 328.4 million.
- Latin America stays the smallest contributor across the period: 8% of revenue in 2025 and 9% in 2034.
- Compressors is projected to grow at 14.03% over the forecast period, the fastest of any product type line.
- The United States is the largest single country market at USD 104.7 million in 2025, 23.8% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by product type, and by application, end-user, system type and component. The headline total carries bear, base and bull cases at USD 866 million and USD 1050 million by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.